Edwards Lifesciences (EW) Change in Inventory (2009 - 2026)

Edwards Lifesciences has reported Change in Inventory for 18 years, with the latest figure at $23.5 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 156.49% year-over-year to $23.5 million in Q2 2026; TTM through Jun 2026 was $15.9 million, a 68.76% decrease from a year earlier, with the FY2025 full-year figure at -$50.7 million, down 119.8% from the prior year.
• Change in Inventory was $23.5 million for Q2 2026 at Edwards Lifesciences, up from $1.6 million in the prior quarter.
• The five-year high for Change in Inventory was $99.3 million in Q4 2023, with the low at -$41.6 million in Q2 2025.
• Average Change in Inventory over 5 years is $40.7 million, with a median of $46.2 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory tumbled 144.16% in 2025, then surged 1500.0% in 2026.
• Over 5 years, Change in Inventory stood at $62.3 million in 2022, then jumped by 59.39% to $99.3 million in 2023, then slumped by 48.44% to $51.2 million in 2024, then slumped by 121.48% to -$11.0 million in 2025, then jumped by 313.64% to $23.5 million in 2026.
• The last three Change in Inventory figures came in at $23.5 million (Q2 2026), $1.6 million (Q1 2026), and -$11.0 million (Q4 2025), per Business Quant data.